- DIRECTOR RECANATI/MILLER TRANSPLANT INSTITUTE
- PROFESSOR | Surgery
- Liver Surgery
- Kidney / Pancreas Transplantation
- Intestinal Transplantation
- Liver Transplantation
- Hospital Affiliation
- The Mount Sinai Hospital
- Recanati/Miller Transplantation Program 212-731-7684212-731-7684
Dr. Florman is the Director of the Recanati/Miller Transplantation Institute and was named the Charles Miller, MD Professor of Surgery.
Visit the Recanati/Miller Transplantation website HERE
Please read the 2013 INSIDE Newsletter Transplant Edition: View the PDF
Dr. Florman discusses liver transplants in The Daily News feature The Daily Check Up. View the PDF.
Dr. Florman discusses organ donation in The Daily News feature View the PDF.
American Board of Surgery
- Chronic Renal Failure
- Hepatitis B
- Hepatitis C
- Kidney Failure
- Kidney Transplant
- Liver Cancer
- Liver Transplant
MD, University of Louisville
Tulane University Medical Center
Tulane University Medical Center
Residency, Surgery (General)
Tulane University Medical Center
A 36 month multi-center, open-label, randomized, comparator study to evaluate the efficacy and safety of everolimus immunosuppression treatment in liver transplantation for hepatocellular carcinoma exceeding Milan criteria
After you have a liver transplant, you will be given drugs called 'immunosuppressants". These types of drugs lower the responses of your immune system so that your body doesn't reject your new organ. When you get a liver transplant because you have had a liver cancer, th...
Florman SS, Podkameni D, Wang L, Gordon RE, Curtiss S, Boros P, Miller CM. Hyperosmolarity associated with diabetes insipidus alters hepatocyte structure and function but not survival after orthotopic liver transplantation in rats. Transplantation 1998 Jan; 65(1).
Florman S, Schiano T, Kim L, Maman D, Levay A, Gondolesi G, Fishbein T, Emre S, Schwartz M, Miller C, Sheiner P. The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clinical transplantation 2004 Apr; 18(2).
Florman S, Toure B, Kim L, Gondolesi G, Roayaie S, Krieger N, Fishbein T, Emre S, Miller C, Schwartz M. Liver transplantation for neuroendocrine tumors. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2004 Feb; 8(2).
Miller C, Florman S, Kim-Schluger L, Lento P, De La Garza J, Wu J, Xie B, Zhang W, Bottone E, Zhang D, Schwartz M. Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004 Oct; 10(10).
Florman S, Burgdorf M, Finigan K, Slakey D, Hewitt R, Nichols RL. Efficacy of double gloving with an intrinsic indicator system. Surgical infections 2005; 6(4).
Florman S, Miller CM. Live donor liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006 Apr; 12(4).
Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. Transplantation 2007 Jun; 83(12).
Paramesh A, Zhang R, Yau CL, Balamuthusamy S, Shenava R, Killackey M, Alper B, Simon E, Slakey D, Florman S. Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults. Clinical nephrology 2009 Jul; 72(1).
Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010 Mar; 16(3).
Durrbach A, Pestana JM, Pearson T, Vincenti F, Garcia VD, Campistol J, Rial Md, Florman S, Block A, Di Russo G, Xing J, Garg P, Grinyó J. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 Mar; 10(3).
Arnon R, Annunziato R, Miloh T, Sogawa H, Nostrand KV, Florman S, Suchy F, Kerkar N. Liver transplantation in children weighing 5 kg or less: analysis of the UNOS database. Pediatric transplantation 2011 Sep; 15(6).
Harbell J, Fung J, Nissen N, Olthoff K, Florman SS, Hanto DW, Light J, Bartlett ST, Tzakis AG, Pearson TC, Barin B, Roland ME, Stock PG. Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery 2012 Sep; 152(3).
Vladeck BC, Florman S, Cooper J. Rationing livers: the persistence of geographic inequity in organ allocation. The virtual mentor : VM 2012 Mar; 14(3).
Chung RT, Gordon FD, Curry MP, Schiano TD, Emre S, Corey K, Markmann JF, Hertl M, Pomposelli JJ, Pomfret EA, Florman S, Schilsky M, Broering TJ, Finberg RW, Szabo G, Zamore PD, Khettry U, Babcock GJ, Ambrosino DM, Leav B, Leney M, Smith HL, Molrine DC. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013 Apr; 13(4).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Florman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.